Insulin Delivery For Diabetes Made Easy (NAPSA)—Medication errors are one of the most common forms of avoidable harm to patients in the United States. Nearly 50 percent of these mistakes involve insulin, which can have significant consequences for people with diabetes who require daily insulin injections to control their disease. Until now, the majority of these people relied on the conventionalvial and syringe methodof insulin delivery, which can bea barrier to accurate dosing. Fortunately, Novolin InnoLet’ (human insulin [rDNAori- gin]), a new, prefilled disposable insulin injection device, can help make injections accurate and easy for the millions of Americans who use insulin. A number of innovative design features make InnoLet user-friendly for anyone who uses insulin. InnoLet hasa dial for setting dosage that looks like a kitchen timer, with large, easy-to-read numbers in oneunit increments. The dial clicks audibly at each dosage level, making it easier to help select the correct dose. InnoLet is also comfortable to hold anduse. It rests securely against the skin, to help minimize tremor or movement at the needle tip; this also helps prevent a patient from injecting too deeply. It can be gripped in a number of ways and hasa large push-button with low resistance. In fact, more than 90 percent of patients in a recent study rated InnoLet as “easiest device to learn howto use.” Through its unique design, People with diabetes may protect themselves from medication errors with proper insulin administration. A new, easy-to-use insulin delivery system can help. InnoLet helps people avoid some of the mistakes commonly associated with the vial and syringe method of insulin delivery, including improper mixing of insulin formulations, difficult-to-read dosage levels, and poor injection technique. More Americans with Type 2 Diabetes Of the estimated 17 million people in the United States that have diabetes, 90 to 95 percent have type 2 diabetes. Currently, 40 percent of those with type 2 diabetes require insulin injections, with 90 percent currently using a vial and syringe. The prevalence of diabetes is expected to rise due to an aging population, obesity and sedentary lifestyles. To learn more about diabetes, including symptomsandthelatest treatment options, speak with your healthcare provider. For moreinformation about InnoLet, visit www. innolet-us.com or call 1-800-7276500. wenn en -e eee eee eee ------ esPXt ee eee eee eee eee Editor’s Note: Any changein insulin should be made cautiously and only under medical supervision. Novolin and InnoLet are registered trademarks of Novo Nordisk A/S.
